cerrar
Tagged with Generics

The US Generic Drug Supply Chain: “Standardized,…
Chip Davis is head of the Association for Accessible Medicines (AAM) which advocates for greater uptake of generic and biosimilar drugs in the USA.…

Mohamed Mabrouk – CEO, Pharmed Healthcare, Egypt
Dr Mohamed Mabrouk, CEO of Pharmed Healthcare, highlights how the company has evolved from only offering Hepatitis C treatment to having 112 products…

Joaquín Vilá – General Manager, Lab Seid, Spain
Lab Seid is a family owned pharmaceutical company based in Barcelona, specialising in branded out of patent products in the field of women’s health.…

Marc Comas – Managing Director, Accord Healthcare Iberia
Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…

USA: The Biosimilars Trade Opportunity
Chip Davis of the Association for Accessible Medicines argues for greater provision for access to affordable medicines – including biosimilars –…

Vincent Pont – President, Laboratoire Arrow, France
Vincent Pont, president of Laboratoire Arrow, explains the company’s history, its collaboration with Aurobindo, the Indian generic pharmaceuticals…

Bertrand de Lavenne – General Manager, Mylan France
Bertrand de Lavenne, general manager of Mylan France, explains how the affiliate is positioned within the group’s operations and how the Mylan…

Pascal Brière – President, Biogaran, France
Pascal Brière, president of Biogaran, the leading French domestic player in generics, reflects on the development of the generic market since the…

Generics: Pioneered by Women
As part of Women’s History Month, Chip Davis, president and CEO of the Association for Accessible Medicines highlights some of the most outstanding…

Jean-Louis Anspach – General Manager, Teva France
Jean-Louis Anspach, general manager of Teva France, elaborates on the affiliate’s transitional restructuring period as they make a turnaround effort…

Sandoz: CEO Quits, Spinoff Rumours Swirl
Richard Francis, CEO of Sandoz will step down at the end of the March. The abrupt announcement will fan the flames of rumours that parent company…

Japan Pharma Market Set for Boom 2019
Already established as one of the world’s leading markets for innovative and patented drugs, Japan is set to grow rapidly in 2019, partly as a…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here